GAITHERSBURG, Md., US, 06 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...

LUND, SWEDEN / ACCESSWIRE / October 31, 2024 / BioInvent International (STO:BINV) "Progress to date brings the company one step closer to addressing the needs for new treatment solutions for patients.

Being an antibody-based therapy, Polivy does not produce the extreme side effects seen with CAR-T either, such as neurotoxicity and cytokine release syndrome (CRS). Roche said adverse reactions ...

No cases of CRS greater than grade 2 were seen in any ... ARX517 showed encouraging phase 1/2 safety and efficacy results at last year’s ESMO congress. Meanwhile, Janux also reported early ...

Shares of Sutro Biopharma (NASDAQ:STRO) fell by 17% in September after the company's ESMO (European Society for Medical Oncology) update. 3-year performance isn't looking much better at -81% ...

FOX ISLAND, Wash. — Despite hearing an evacuation order for the Ford Corkscrew Fire north of Spokane, John Lowe stayed and fought the wildfire charging over the hillside and toward his home in ...

The A- insurance financial strength rating of a reinsurer of asset intensive life and annuity liabilities has been affirmed by ratings agency KBRA, which said the outlook for the rating was stable.

“Lobular has now been featured at all the major conferences — ESMO, ASCO, SABCS and others,” he said. “But we need more money and we need much more research.” While the loss of E-cadherin underpins ...

AMD reported decent Q3 results, surpassing expectations on revenue, with significant growth in the Data Center segment. The company only matched bottom line estimates, and current quarter guidance ...

Join members of the development team at Remedy Entertainment for a behind-the-scenes look at FBC: Firebreak, an upcoming 3-player cooperative first-person shooter set within the enigmatic Federal ...